Agenus Inc. (AGEN) Q3 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Agenus Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.489 -- 00:00:04.732 Good morning. My name is Jeannie and I will be your conference operator today. 00:00:04.732 -- 00:00:09.514 At this time, I would like to welcome everyone to the AGENAS 00:00:09.775 -- 00:00:12.838 Q3 2023 Earnings Conference Call. 00:00:12.838 -- 00:00:17.301 All lines have been placed on mute to prevent any background noise. 00:00:17.301 -- 00:00:21.764 After the speaker's remarks, there will be a question and answer session. 00:00:21.764 -- 00:00:25.827 If you would like to ask a question during this time, simply press star followed by the 00:00:25.827 -- 00:00:28.795 number one on your telephone keypad. 00:00:28.795 -- 00:00:33.677 If you would like to withdraw your question, again, press the star 1. 00:00:33.677 -- 00:00:38.658 Thank you. Zach Arman, you may begin your conference. 00:00:39.660 -- 00:00:42.581 Thank you, operator, and thank you all for joining us today. 00:00:42.581 -- 00:00:48.303 Today's call is being webcast and will be available on our website for replay. 00:00:48.303 -- 00:00:52.285 I'd like to remind you that this call will include forward-looking statements, including 00:00:52.285 -- 00:00:57.688 statements regarding our clinical development, regulatory, and commercial plans and timelines. 00:00:57.688 -- 00:01:03.274 as well as timelines for data release and partnership opportunities, among other updates. 00:01:03.274 -- 00:01:07.538 These statements are subject to risks and uncertainties, and we refer you to our ITC 00:01:07.538 -- 00:01:12.403 filings available on our website for more details on these risks. 00:01:12.403 -- 00:01:17.168 Joining me today are Dr. Garrow Harmon, Chairman and Chief Executive Officer, Dr. 00:01:17.168 -- 00:01:20.650 Stephen O'Day, Chief Medical Officer, 00:01:27.551 -- 00...